Jeisys Medical Inc
KOSDAQ:287410
Jeisys Medical Inc
Total Receivables
Jeisys Medical Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Total Receivables
₩16.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
240%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Receivables
₩69.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Receivables
₩61.5B
|
CAGR 3-Years
93%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Receivables
₩20B
|
CAGR 3-Years
901%
|
CAGR 5-Years
482%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Receivables
₩7.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Receivables
₩4.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
See Also
What is Jeisys Medical Inc's Total Receivables?
Total Receivables
16.1B
KRW
Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Total Receivables amounts to 16.1B KRW.
What is Jeisys Medical Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
240%
Over the last year, the Total Receivables growth was 25%. The average annual Total Receivables growth rates for Jeisys Medical Inc have been 38% over the past three years , 240% over the past five years .
